查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566758

玻璃体视网膜手术器械市场：依产品类型、手术类型、最终用户：2024-2033 年全球机会分析与产业预测

Vitreoretinal Surgery Devices Market By Product , By Surgery Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

玻璃体视网膜手术装置

2023年玻璃体视网膜手术器械市值为23亿美元，预计2024年至2033年复合年增长率为5.9%，到2033年达到41亿美元。

玻璃体视网膜手术设备是一种专门设备，对于进行针对眼睛视网膜和玻璃体的眼科手术至关重要。使用这些设备可以治疗多种视网膜疾病，例如黄斑裂孔、视网膜剥离、糖尿病视网膜病变和视网膜前膜，以修復和恢復眼睛的正常解剖结构和功能。设备创新可实现微创手术，进而缩短恢復时间并改善患者的治疗效果。

眼科手术的普及，特别是在老年族群中，是玻璃体视网膜手术设备市场的关键驱动因素。此外，政府在医疗保健设施上的支出增加导致玻璃体视网膜手术设备的进步，支持其在医疗实践中的采用。目前，将机器人技术整合到手术设备中是市场的新趋势。在如此复杂的手术中，这项技术优于人类技术，减少了出错的机会并提高了精确度。研究人员的目标是透过结合机器人技术和人工智慧来实现智慧手术。

然而，采购玻璃体视网膜手术设备的高昂初始成本和维护要求阻碍了小型医疗机构的投资。这限制了各个新兴国家和服务欠缺地区的市场成长。相较之下，眼科疾病的数量不断增加，预计未来将推动玻璃体视网膜手术设备的采用。根据 Bright Focus 基金会 2022 年 10 月发布的情况说明书，美国约有 1,100 万人患有某种形式的老龄化黄斑部病变。该基金会预测，到 2050 年，这一数字将翻一番，达到近 2,200 万，迫使人们使用治疗设备。

板块回顾

玻璃体视网膜手术器械市场分为产品、手术类型、最终用户和地区。依产品，市场分为全氟化碳流体、内部照明装置、玻璃体视网膜预填充硅胶注射器、玻璃体切除系统等。根据手术类型，市场分为前部视网膜玻璃体手术和后部视网膜玻璃体手术。依最终用户划分，可分为医院、专科诊所和门诊手术中心。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

从产品来看，玻璃体切割系统细分市场将在 2023 年占据主导地位。

按手术类型划分，前视网膜玻璃体手术细分市场在 2023 年占据了较高的市场份额。

按最终用户划分，医院细分市场在 2023 年占据最高市场占有率。

按地区划分，北美地区 2023 年收益最高。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章玻璃体视网膜手术器械市场：依产品

  • 市场概况
  • 全氟化碳液
  • 内部照明设备
  • 玻璃体视网膜预填充硅胶注射器
  • 玻璃体切除系统
  • 其他的

第五章玻璃体视网膜手术器械市场：依手术类型

  • 市场概况
  • 前视网膜玻璃体手术
  • 视网膜后玻璃体手术

第六章玻璃体视网膜手术器械市场：依最终用户分类

  • 市场概况
  • 医院
  • 专科诊所
  • 门诊手术中心

第七章血管手术器械市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国玻璃体视网膜手术器械市场
    • 加拿大玻璃体视网膜手术设备市场
    • 墨西哥玻璃体视网膜手术器械市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国玻璃体视网膜手术器械市场
    • 法国玻璃体视网膜手术器械市场
    • 英国玻璃体视网膜手术器械市场
    • 义大利玻璃体视网膜手术器械市场
    • 西班牙玻璃体视网膜手术器械市场
    • 其他欧洲玻璃体视网膜手术器械市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本玻璃体视网膜手术器械市场
    • 中国玻璃体视网膜手术器械市场
    • 澳洲玻璃体视网膜手术器械市场
    • 印度玻璃体视网膜手术器械市场
    • 韩国玻璃体视网膜手术器械市场
    • 其他亚太玻璃体视网膜手术器械市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西玻璃体视网膜手术器械市场
    • 沙乌地阿拉伯的玻璃体视网膜手术设备市场
    • 南非玻璃体视网膜手术器械市场
    • 其他拉丁美洲/中东/非洲玻璃体视网膜手术设备市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Bausch And Lomb
  • Novartis AG
  • Inami And Co
  • Paragon Care Group Pty Ltd
  • Oculus Inc
  • MedOne Surgical, Inc
  • Carl Zeiss Meditec AG
  • Peregrine Surgical
  • Johnson And Johnson
  • Blink Medical
简介目录
Product Code: A00914

Vitreoretinal Surgery Devices

The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Vitreoretinal surgery devices are the specialized equipment essential to perform ophthalmic surgeries focused on retina and vitreous humor of eyes. Diverse retinal conditions such as macular holes, retinal detachments, diabetic retinopathy, and epiretinal membranes are treated using these devices for the repair & restoration of the normal anatomy and function of the eyes. Innovations in devices allow surgeries to be performed with minimal invasion, hence lowering the recovery times and improving patient outcomes.

Increase in the prevalence of eye surgeries, particularly among the old generation, is a key driver of the vitreoretinal surgery devices market. In addition, rise in expenditure by the government toward healthcare facilities has led to advancements in the vitreoretinal surgery devices, which is boosting their adoption in the healthcare settings. Currently, the integration of robotics technology into surgery devices is an emerging trend in the market. The technology exceeds human skills in such complex surgeries, reducing the possibility of errors and enhancing the precision. The researchers aim to create smart surgery procedures by the assimilation of robotics and AI.

However, the high upfront costs of procuring the vitreoretinal surgery devices, along with their maintenance requirements deters various small-scale healthcare facilities from investing in them. This restrains the market growth in various developing and underserved regions. Contrarily, the constantly rising numbers of eye conditions are projected to boost the adoption of vitreoretinal surgery devices in the future. According to a factsheet released by Bright Focus Foundation on October 2022, approximately 11 million individuals in the U.S. suffer from some form of age-related macular degeneration. The foundation anticipates the number to double to nearly 22 million by 2050, hence compelling the use of the devices for treatment.

Segment Review

The vitreoretinal surgery devices market is segmented into product, surgery type, end user, and region. On the basis of product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. Depending on surgery type, the market is bifurcated into anterior vitreoretinal surgery and posterior vitreoretinal surgery. As per end user, it is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the vitrectomy system segment dominated the market in 2023.

Depending on surgery type, the anterior vitreoretinal surgery segment acquired a high stake at the market in 2023.

As per end user, the hospitals segment accounted for a high market share in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global vitreoretinal surgery devices market include Bausch & Lomb, Novartis AG, Inami & Co, Paragon Care Group Pty Ltd, Oculus Inc, MedOne Surgical, Inc, Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson, and Blink Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Perfluorocarbon Liquids
  • Endoillumination Instrument
  • Vitreoretinal Prefilled Silicone Oil Syringes
  • Vitrectomy System
  • Other

By Surgery Type

  • Anterior Vitreoretinal Surgery
  • Posterior Vitreoretinal Surgery

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Bausch & Lomb
    • Novartis AG
    • Inami & Co
    • Paragon Care Group Pty Ltd
    • Oculus Inc
    • MedOne Surgical, Inc
    • Carl Zeiss Meditec AG
    • Peregrine Surgical
    • Johnson & Johnson
    • Blink Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VITREORETINAL SURGERY DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Perfluorocarbon Liquids
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Endoillumination Instrument
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Vitreoretinal Prefilled Silicone Oil Syringes
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Vitrectomy System
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Other
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: VITREORETINAL SURGERY DEVICES MARKET, BY SURGERY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Surgery Type
  • 5.2. Anterior Vitreoretinal Surgery
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Posterior Vitreoretinal Surgery
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: VITREORETINAL SURGERY DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: VITREORETINAL SURGERY DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Surgery Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Vitreoretinal Surgery Devices Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Surgery Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Vitreoretinal Surgery Devices Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Surgery Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Vitreoretinal Surgery Devices Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Surgery Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Surgery Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Vitreoretinal Surgery Devices Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Surgery Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Vitreoretinal Surgery Devices Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Surgery Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Vitreoretinal Surgery Devices Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Surgery Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Vitreoretinal Surgery Devices Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Surgery Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Vitreoretinal Surgery Devices Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Surgery Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Vitreoretinal Surgery Devices Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Surgery Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Surgery Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Vitreoretinal Surgery Devices Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Surgery Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Vitreoretinal Surgery Devices Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Surgery Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Vitreoretinal Surgery Devices Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Surgery Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Vitreoretinal Surgery Devices Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Surgery Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Vitreoretinal Surgery Devices Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Surgery Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Surgery Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Surgery Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Vitreoretinal Surgery Devices Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Surgery Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Vitreoretinal Surgery Devices Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Surgery Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Vitreoretinal Surgery Devices Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Surgery Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Vitreoretinal Surgery Devices Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Surgery Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Bausch And Lomb
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Novartis AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Inami And Co
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Paragon Care Group Pty Ltd
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Oculus Inc
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. MedOne Surgical, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Carl Zeiss Meditec AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Peregrine Surgical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Johnson And Johnson
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Blink Medical
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments